BionetworkConsulting

San Diego

San Diego

Life Sciences Consulting Services in San Diego for Biotech, Pharma and Medical Device Companies

San Diego’s life sciences sector brings together biotechnology innovators, pharmaceutical developers, medical device manufacturers, and clinical research organizations working to advance healthcare. Moving a scientific concept toward a viable product requires more than laboratory research. Companies must coordinate development activities, establish dependable quality systems, manage clinical data, select qualified partners, and prepare for regulatory milestones. BioNetwork Consulting provides specialized support for these business and technical challenges. Our services help life sciences organizations address gaps in regulatory planning, computerized systems, clinical workforce capacity, and development operations. From early-stage biotechnology companies preparing for their first regulatory submission to established manufacturers reviewing their quality processes, we tailor our consulting approach to the requirements of each engagement.

Regulatory Strategy

Regulatory Strategy for Complex Product Development

Every life sciences product follows a development pathway shaped by its intended use, risk profile, evidence requirements, and applicable regulations. Selecting the appropriate strategy early can help organizations identify documentation needs, anticipate resource requirements, and avoid preventable development delays.

BioNetwork Consulting supports regulatory strategy and submission planning for pharmaceutical, biotechnology, and medical device programs. Our services include IND application consulting, FDA IND submission consulting, IDE application consulting, regulatory submission services, and regulatory CMC consulting.

For companies preparing medical devices for the US market, our consulting scope can include 510(k) submission planning, medical device labeling considerations, and ISO 14971 risk management. Pharmaceutical organizations may require guidance on applicable requirements under 21 CFR Parts 210 and 211, while biotechnology developers may need support coordinating manufacturing, quality, and clinical documentation.

We also assist organizations evaluating combination product regulatory consulting, cell and gene therapy regulatory considerations, and digital health regulatory consulting. The objective is to align development activities with the relevant regulatory pathway rather than apply a generic strategy across different product categories.

Computer System Validation for Regulated Digital Environments

A laboratory information management system, electronic data capture platform, manufacturing application, or quality management system can influence critical product and patient information. Implementing software without adequate controls can create problems involving data traceability, access permissions, audit trails, and documented evidence of system performance.

Our computer system validation consulting services help organizations establish a structured approach to computerized systems used in regulated operations.

Projects may involve:

  • Defining intended use, system requirements, and validation scope.
  • Assessing risks associated with electronic records and regulated processes.
  • Preparing validation protocols, test evidence, and traceability documentation.
  • Evaluating system changes, deviations, and ongoing maintenance requirements.
  • Reviewing data integrity controls and preparing documentation for audits.

We also support EDC system validation, clinical trial software oversight, CTMS optimization, and eTMF compliance initiatives. For organizations adopting newer technologies, AI system validation and GxP compliance for AI may be relevant where automated tools affect regulated activities.

By connecting system functionality with documented quality requirements, companies can improve oversight of their technology environment and make better-informed implementation decisions.

Computer System Validation
Quality Management

Quality Management, FDA Audits and Compliance Remediation

A quality management system should do more than store procedures. It should help teams identify problems, investigate their causes, document decisions, and prevent recurring failures.

BioNetwork Consulting supports quality assurance consulting, QMS consulting, regulatory compliance consulting, and GxP gap assessment consulting for life sciences organizations seeking to evaluate their existing processes.

Our work can address internal audit consulting, supplier audit services, vendor qualification consulting, CAPA management consulting, and FDA inspection readiness consulting.

For example, a company preparing for an inspection may need to review training records, verify the status of corrective actions, examine document-control practices, and confirm that identified deviations have been investigated appropriately. A growing biotechnology business may instead need to establish procedures, assign quality responsibilities, and implement a scalable management system.

Our consulting approach focuses on identifying specific weaknesses and prioritizing corrective measures according to operational and regulatory risk. GxP training and regulated change management can further help employees understand their responsibilities when procedures, systems, or processes change.

Biostatistics and Clinical Data Management

Clinical evidence must be generated and interpreted using methods appropriate to the study objectives. Inadequate statistical planning, inconsistent data handling, or poorly defined analysis requirements can undermine the usefulness of study results.

BioNetwork Consulting offers biostatistics consulting services for organizations requiring support with clinical study planning and statistical analysis. Depending on project scope, this may include biostatistics analysis, biostatistical consulting, clinical trial statistical consulting, and biostatistics programming consulting.

Our broader consulting capabilities can also support clinical data management, clinical data governance, and GxP data management initiatives.

Organizations planning adaptive clinical trials may need to evaluate statistical assumptions, operational feasibility, and the implications of interim analyses. Similarly, sponsors preparing study reports need consistent analysis methods and clearly documented decisions.

For companies working with large or complex datasets, EHR data analytics, clinical data analytics consulting, and real-world evidence consulting may provide additional opportunities to assess patient populations and generate insights relevant to development planning.

biostatistics
Clinical Trial Recruitment

Clinical Trial Recruitment and Workforce Planning

Clinical development requires coordination between research sites, sponsors, vendors, and specialized professionals. When a study expands or enters a demanding phase, staffing gaps can affect monitoring activities, documentation quality, and operational timelines.

Our clinical trial recruitment and biotech recruiting services help organizations identify professionals suited to their technical and operational requirements. Recruitment needs may include clinical research associates, clinical project managers, study coordinators, regulatory affairs specialists, clinical data professionals, and quality assurance personnel.

Beyond individual placements, recruitment consulting can support workforce planning, role definition, candidate assessment, and recruitment process improvement.

We also recognize that study performance depends on more than staffing. Clinical operations consulting, clinical trial site management, trial enrollment optimization, and patient retention clinical trials strategies can help organizations evaluate recruitment bottlenecks and improve coordination across study activities.

For studies experiencing significant delays, clinical trial rescue and trial recovery services may involve assessing site performance, enrollment assumptions, vendor responsibilities, and execution risks before developing a prioritized recovery plan.

Vendor Selection, Technology Transfer and Development Operations

External partners often perform essential functions in pharmaceutical and biotechnology development. Selecting an unsuitable contract development and manufacturing organization or technology provider can introduce quality concerns, communication gaps, and unexpected costs.

BioNetwork Consulting supports CDMO vendor selection, vendor selection consulting, vendor qualification consulting, and life sciences vendor management. These services can help organizations define selection criteria, evaluate supplier capabilities, review quality documentation, and establish appropriate oversight processes.

For programs moving from development toward manufacturing, technology transfer consulting can help teams organize technical information, clarify responsibilities, and identify gaps that require attention before a transfer proceeds.

Our broader life sciences process optimization and pharmaceutical R&D consulting capabilities can also support operational assessments, development planning, and coordination between technical and quality functions.

The right approach depends on the product, manufacturing model, project stage, and responsibilities assigned to each partner.

Clinical Trial Recruitment
Digital Health and Post-Market Compliance

Emerging Priorities in AI, Digital Health and Post-Market Compliance

Life sciences organizations are increasingly evaluating AI-enabled workflows, connected medical technologies, and digital health products. These developments create new questions about software performance, data quality, oversight, and regulatory classification.

Our consulting scope can include AI governance consulting, generative AI compliance, AI regulatory compliance consulting, and Software as a Medical Device (SaMD) regulatory considerations.

Organizations developing regulated software may need to assess intended use, document risk controls, and determine which regulatory requirements apply to their product. Companies with marketed products may also require support evaluating pharmacovigilance services, adverse event reporting processes, medical device vigilance, and post-market surveillance obligations.

Addressing these requirements during planning and implementation can help organizations establish clearer responsibilities and maintain appropriate oversight throughout the product lifecycle.

Work with BioNetwork Consulting in San Diego

BioNetwork Consulting works with pharmaceutical companies, biotechnology startups, CROs, CDMOs, and medical device manufacturers seeking targeted expertise for specific development and compliance challenges.

Rather than treating every project as a broad consulting engagement, we focus on understanding the issue, defining the required deliverables, and identifying the expertise needed to address it. Whether your priority is computer system validation, FDA audit preparation, biostatistics consulting, clinical trial recruitment, or vendor qualification, we can discuss a suitable scope of support.

Contact BioNetwork Consulting to discuss your San Diego life sciences project and identify the consulting services that best match your development, technology, or regulatory requirements.

life sciences consulting
Scroll to Top